Purdue Pharma is offering to pay up to $6 billion to victims who say they got addicted to the company’s drugs. But the deal would protect the Sackler family, the owners of the drug maker, from future lawsuits.
On Dec. 4, the Supreme Court heard the opening arguments in the bankruptcy settlement case. How intentional were Purdue Pharma’s sales tactics? To find out we spoke with a former salesperson for Purdue Pharma, Carol Panara.